Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Isabella Glitza-Oliva"'
A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic Melanoma
Autor:
Mohamed A. Gouda, Bettzy Stephen, Yanyan Tian, Anas Alshawa, Dilichukwu O. Chudy Onwugaje, Aya Albittar, Yali Yang, Abdulrazzak Zarifa, Bulent Yilmaz, Serdar Gurses, Ashabari Sprenger, Mohamed H. Derbala, Amanda Brink, Jeffrey Andrew How, Justin Moyers, Sarina A. Piha-Paul, David S. Hong, Funda Meric-Bernstam, Sapna P. Patel, Isabella Glitza Oliva
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Vol 7, Iss 4, Pp 247-254 (2024)
Introduction: Immune checkpoint inhibitors (ICIs) have substantially advanced the treatment of patients with malignant melanoma. However, improving therapeutic efficacy requires identifying drug combinations that elicit durable responses without indu
Externí odkaz:
https://doaj.org/article/01ddbd01535c420dae060977a04da2eb
Autor:
Isabella Glitza Oliva, Omid Hamid, Patrick Ott, Genevieve Boland, Ryan Sullivan, Kenneth Grossmann, Christopher Desjardins, Nathan Hicks, Brian Weiner, Farah Alayli, Christine Spencer, Shikha Guatam, Christopher Loo, Benjamin Kamphaus, Julie Densmore, Christopher Cabanski, Diane Da Silva, Jennifer Wargo, Justin Fairchild, Marko Spasic, John Aunins, Kelly Brady, Elizabeth Burton, Jennifer Wortman, Theresa LaVallee, Mathew Henn, Hussein Tawbi
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Antonio Pizuorno Machado, Malek Shatila, Cynthia Liu, Yang Lu, Mehmet Altan, Isabella Glitza Oliva, Dan Zhao, Hao Chi Zhang, Anusha Thomas, Yinghong Wang
Publikováno v:
Journal of cancer research and clinical oncology.
Purpose: Exposure to immune checkpoint inhibitors (ICIs) can predispose to immune-related adverse events (irAEs) involving the gastrointestinal tract. The association between ICIs and bowel perforation has not been well studied. We aimed to describe
Autor:
Antony Mathew, Malek Shatila, Zongshan Lai, Dongfeng Tan, Isabella Glitza Oliva, Jianbo Wang, Omar Alhalabi, Hao Chi Zhang, Anusha S. Thomas, Yinghong Wang
Publikováno v:
American Journal of Gastroenterology. 117:e133-e134
Autor:
Isabella Glitza Oliva, Sherise Ferguson, Roland Bassett, Alexandra Foster, Ida John, Tarin Hennegan, Michelle Rohlfs, Jessie Richard, Masood Iqbal, Tina Dett, Carol Lacey, Natalie Jackson, Theresa Rodgers, Suzanne Phillips, Sheila Duncan, Lauren Haydu, Rodabe Amaria, Michael Wong, Adi Diab, Cassian Yee, Sapna Patel, Jennifer McQuade, Grant Fischer, Ian McCutcheon, Barbara O'Brien, Sudhakar Tummala, Matthew Debnam, Nandita Guha-Thakurta, Jennifer Wargo, Elizabeth Burton, Hussein Tawbi, Michael Davies
There is a critical need for effective treatments for leptomeningeal disease (LMD). We conducted a single-arm, first-in-human phase I/Ib study of concurrent intrathecal (IT) and intravenous (IV) nivolumab in melanoma patients with LMD. The primary en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84a8db49b7e5e654ccdfe8c7f6ed372f
https://doi.org/10.21203/rs.3.rs-1397403/v1
https://doi.org/10.21203/rs.3.rs-1397403/v1
Autor:
Debasish Boral, Dario Marchetti, Monika Vishnoi, Haowen Liu, Isabella Glitza-Oliva, Thomas Welte, Marc L. Sprouse
Publikováno v:
Clinical Cancer Research. 26:B23-B23
Intratumoral infiltration of myeloid-derived suppressor cells (MDSCs) is known to promote neoplastic growth by inhibiting the tumoricidal activity of T cells. However, direct interactions between patient-derived MDSCs and circulating tumors cells (CT
Autor:
Debalina Goswami-Sewell, Debasish Boral, Haowen N. Liu, Guangsheng Pei, Isabella Glitza-Oliva, Monika Vishnoi, Wei Yin, Lili Li, Thomas Welte, Marc L. Sprouse, Peilin Jia, Dario Marchetti
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 20, Iss 8, p 1916 (2019)
Volume 20
Issue 8
International Journal of Molecular Sciences, Vol 20, Iss 8, p 1916 (2019)
Volume 20
Issue 8
Intratumoral infiltration of myeloid-derived suppressor cells (MDSCs) is known to promote neoplastic growth by inhibiting the tumoricidal activity of T cells. However, direct interactions between patient-derived MDSCs and circulating tumors cells (CT
Autor:
Dzifa Y. Douse, Chieh Lan, Lauren E. Haydu, Michael Davies, Sinchita Roy-Chowdhuri, Leomar Y. Ballester, Rajyalakshmi Luthra, Ignacio I. Wistuba, Jason T. Huse, Isabella Glitza-Oliva
Publikováno v:
Cancer Genetics. :34